sVEGFR2 and circulating tumor cells to predict for the efficacy of pazopanib in neuroendocrine tumors (NETs): PAZONET subgroup analysis.
Enrique Grande
No relevant relationships to disclose
Oriol Casanovas
No relevant relationships to disclose
Julie Earl
No relevant relationships to disclose
Daniel E. Castellano
No relevant relationships to disclose
Rocio Garcia-Carbonero
No relevant relationships to disclose
Alex Teule
No relevant relationships to disclose
Ignacio Duran
No relevant relationships to disclose
Jose Fuster
No relevant relationships to disclose
Isabel Sevilla
No relevant relationships to disclose
Pilar Escudero
No relevant relationships to disclose
Javier Sastre
No relevant relationships to disclose
Jesús García-Donas
No relevant relationships to disclose
Luis Ortega
No relevant relationships to disclose
Juan Jose Diez
No relevant relationships to disclose
Ainara Soria Rivas
No relevant relationships to disclose
Jaume Capdevila
No relevant relationships to disclose